Cost-effectiveness analysis in heart disease, Part I: General principles.
about
Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain.Costs and effectiveness of cardiac rehabilitation for dialysis patients following coronary bypassCost-effective strategies for the management of vascular disease.
P2860
Cost-effectiveness analysis in heart disease, Part I: General principles.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cost-effectiveness analysis in heart disease, Part I: General principles.
@en
type
label
Cost-effectiveness analysis in heart disease, Part I: General principles.
@en
prefLabel
Cost-effectiveness analysis in heart disease, Part I: General principles.
@en
P2093
P1476
Cost-effectiveness analysis in heart disease, Part I: General principles.
@en
P2093
Holmes-Rovner M
Kupersmith J
P304
P356
10.1016/S0033-0620(05)80041-6
P577
1994-11-01T00:00:00Z